SpringerLink
Log in

The Emerging Field of Precision Medicine – The New Paradigm for Healthcare

  • Chapter
  • First Online:
Global Perspectives on Precision Medicine

Part of the book series: Advancing Global Bioethics ((AGBIO,volume 19))

  • 185 Accesses

Abstract

Precision medicine is anticipated as the emerging approach to medicine that will make more effective prevention, diagnosis, and treatment, by develo** a “deep understanding” of patients’ genetic and genomic information, thereby moving away from the current “one-size-fits-all” treatment. Since the launch of the Precision Medicine Initiative in 2015 by the Obama administration, the United States, along with countries including Canada, the United Kingdom, and Estonia is working towards a precision medicine priority through the development of national biobanks that are essential components for providing the “big data.” National biobanks are critical for different countries as they not only collect valuable data and biological samples but also add to the critical knowledge that can impact the needed understanding for the success of PM. As such most countries are in this race to implement a PM initiative. Although, PM is held at a high esteem as the innovative technology in healthcare, it has been argued that implementing PM into routine clinical setting will need to address considerable challenges that include addressing ethical issues and making sure PM research and technology is equitable and aligned with the needs of the global population. This chapter gives an overview of PM, and the anticipated issues.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (Canada)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (Canada)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (Canada)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (Canada)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aceti, A. 2016. Pharmacogenomics for infectious diseases. Journal of Medical Microbiology & Diagnosis 5 (1): 1–2.

    Article  Google Scholar 

  • Adams, S.A., and Carolyn Petersen. 2016. Precision medicine: Opportunities, possibilities, and challenges for patients and providers. Journal of the American Medical Informatics Association 23 (4): 787–790.

    Article  Google Scholar 

  • Armstrong, J., et al. 2015. American BRCA outcomes and utilization of testing (ABOUT) study: A pragmatic research model that incorporates personalized medicine/patient-centered outcomes in a real world setting. Journal of Genetic Counseling 24: 18–28.

    Article  Google Scholar 

  • Aronson, Samuel J., and Heidi L. Rehm. 2015. Building the foundation for genomics in precision medicine. Nature 526: 336–342.

    Article  Google Scholar 

  • Beery, T.A., and Carolyn R. Smith. 2011. Genetics/genomics advances to influence care for patients with chronic disease. Rehabilitation Nursing: The Official Journal of the Association of Rehabilitation Nurses 36 (2): 54–61.

    Article  Google Scholar 

  • Blackburn, D. 2019. NEJM abstract: The “All of Us” research program. FedHealthIt. Retrieved from: https://www.fedhealthit.com/2019/08/nejm-abstract-the-all-of-us-research-program/.

    Google Scholar 

  • Blasimme, A., and Effy Vayena. 2016. Becoming partners, retaining autonomy: Ethical considerations on the development of precision medicine. BMC Medical Ethics 17: 1–8.

    Article  Google Scholar 

  • Bledsoe, M.J. 2017. Ethical legal and social issues of Biobanking: Past, present, and future. Biopreservation and Biobanking 15 (2): 142–147.

    Article  Google Scholar 

  • Branković, I., Jelena Malogajski, and Servaas A. Morré. 2014. Biobanking and translation of human genetics and genomics for infectious diseases. Applied & Translational Genomics 3: 30–35.

    Article  Google Scholar 

  • Bunton, Robin, and Lesley Jones. 2010. Visions of the public and private in public health genomics: The case of a nascent Australian biobank. New Genetics and Society 29 (4): 413–429.

    Article  Google Scholar 

  • Chenoweth, M.J., et al. 2020. Global pharmacogenomics within precision medicine: Challenges and opportunities. Clinical Pharmacology & Therapeutics 107 (1): 1–8.

    Article  Google Scholar 

  • Etchegary, H. 2015. Community engagement with genetics: Public perceptions and expectations about genetics research. Health Expectations 18 (5): 1413–1425.

    Google Scholar 

  • Chin, William Wei Lim, et al. 2016. Ethics reporting in biospecimen and genetic research: Current practice and suggestions for changes. Plos Biology 14 (8): 1–6.

    Article  Google Scholar 

  • Chow-White, P.A., et al. 2015. From the bench to the bedside in the big data age: Ethics and practices of consent and privacy for clinical genomics and personalized medicine. Ethics and Information Technology 17 (3): 189–200.

    Article  Google Scholar 

  • Collins, F.S., and Harold Varmus. 2015. A new initiative on precision medicine. The New England Journal of Medicine 372 (9): 793–795.

    Article  Google Scholar 

  • Costa, F. 2014. Big data in biomedicine. Drug Discovery Today 19: 433–440.

    Article  Google Scholar 

  • Daly, A.K. 2013. Pharmacogenomics of adverse drug reactions. Daly Genome Medicine 5 (5): 1–12.

    Google Scholar 

  • Demir, Ipek, and Madeleine J. Murtagh. 2013. Data sharing across biobanks: Epistemic values, data mutability and data incommensurability. New Genetics and Society 32 (4): 350–365.

    Article  Google Scholar 

  • Denny, J.C., et al. 2019. The “All of US” research program. The New England Journal of Medicine 381 (7): 668–676.

    Google Scholar 

  • Dove, E.S. 2015. Biobanks, data sharing, and the drive for a global privacy governance framework. Privacy Laws and International Biobank Research 43: 675–689.

    Google Scholar 

  • Dressler, L.G., et al. 2014. Genomics education for the public: Perspectives of genomic researchers and ELSI advisors. Genetic Testing and Molecular Biomarkers 18 (3): 131–140.

    Article  Google Scholar 

  • Dua, J., et al. 2011. Pharmacogenomics- a boon for chronic diseases. International Journal of Pharma and Bio Sciences 2 (2): 423–430.

    Google Scholar 

  • Duffy, D.J. 2016. Problems, challenges and promises: Perspectives on precision medicine. Briefings in Bioinformatics 17 (3): 494–504.

    Article  Google Scholar 

  • Elger, Bernice S., and Arthur L. Caplan. 2006. Consent and anonymization in research involving biobanks: Differing terms and norms present serious barriers to an international framework. European Molecular Biology Organization 7 (7): 661–666.

    Google Scholar 

  • Fletcher, Amy. 2008. Governing DNA: Prospects and problems in the proposed large-scale United States population cohort study. In Biobanks: Governance in comparative perspective, ed. Herbert Gottweis and Alan Peterson. New York: Routledge.

    Google Scholar 

  • Fradkin, J.E., Mary C. Hanlon, and Griffin P. Rodgers. 2016. NIH precision medicine initiative: Implications for diabetes research. Diabetes Care 39 (7): 1080–1084.

    Article  Google Scholar 

  • Frizzo-Barker, J., et al. 2016. Genomic big data and privacy: Challenges and opportunities for precision medicine. Computer Supported Cooperative Work (CSCW) 25 (2–3): 115–136.

    Article  Google Scholar 

  • Godman, B., et al. 2013. Personalizing health care: Feasibility and future implications. BMC Medicine 11 (79): 1–23.

    Google Scholar 

  • Gottweis, Herbert. 2008. New strategies in the governance of life. In Biobanks: Governance in comparative perspective, ed. Herbert Gottweis and Alan Peterson. New York: Routledge.

    Google Scholar 

  • Gottweis, Herbert, and Alan Petersen, eds. 2008. Biobanks: Governance in comparative perspective. New York: Routledge.

    Google Scholar 

  • Harris, Jennifer R., et al. 2012. Toward a roadmap in global biobanking for health. European Journal of Human Genetics 20: 1105–1111.

    Article  Google Scholar 

  • Hawkins, A.K., and K. O’Doherty. 2010. Biobank governance: A lesson in trust. New Genetics & Society 29 (3): 311–327.

    Article  Google Scholar 

  • Huppertz, Berthold, and Andreas Holzinger. 2014. Biobanks – A source of large biological data sets: Open problems and future challenges. In Knowledge discovery and data mining, 317–330. Berlin: Springer.

    Google Scholar 

  • Iriart, J.A.B. 2019. Precision medicine/personalized medicine: A critical analysis of movements in the transformation of biomedicine in the early 21st century. Cad Saúde Pública 35 (3): 1–13.

    Google Scholar 

  • Javitt, Gail H. 2013. Take another little piece of my Heart1: Regulating the research use of human biospecimens. Journal of Law, Medicine & Ethics 41: 424–439.

    Article  Google Scholar 

  • Joly, Yann, et al. 2014. The ethical framing of personalized medicine. Current Opinion in Allergy and Clinical Immunology 14 (5): 404–408.

    Article  Google Scholar 

  • Kaufman, D.J., et al. 2016. A survey of U.S adults’ opinions about conduct of a Nationwide Precision Medicine Initiative® Cohort study of genes and environment. PLos One 11 (8): 1–14.

    Article  Google Scholar 

  • Kaye, J., et al. 2010. Ethical implications of the use of whole genome methods in medical research. European Journal of Human Genetics 18 (4): 398–403.

    Article  Google Scholar 

  • Lucero, J., and Y. Roubideaux. 2020. Holding space for all of us. American Medical Association Journal of Ethics 22 (10): E882–E887.

    Google Scholar 

  • Mann, D.L., and L. Kristin Newby. 2016. Will the precision medicine initiative transform cardiovascular translational research? Basic to Translational Science 1 (4): 1–2.

    Google Scholar 

  • Martin-Sanchez, F., and K. Verspoor. 2014. Big data in medicine is driving big changes. IMIA Yearbook of Medical Informatics 9: 14–20.

    Google Scholar 

  • Maschke, Karen J. 2005. Navigating an ethical patchwork—Human gene banks. Nature Biotechnology 23 (5): 539–545.

    Google Scholar 

  • Maschke, Karen J. 2008. Biobanks: DNA and Research. In From birth to death and bench to clinic: The Hastings Center Bioethics Briefing Book for Journalists, Policymakers, and Campaigns, ed. Mary Crowley. Garrison: The Hastings Center.

    Google Scholar 

  • Mayrhofer, Michaela. 2008. Patient organizations as the (un)usual suspects: The biobanking activities of the Association Fracaise contre les Myopathies and its Genethon DNA and Cell Bank. In Biobanks: Governance in comparative perspective, ed. Herbert Gottweis and Alan Peterson. New York: Routledge.

    Google Scholar 

  • McArthur, A.G., and Kara K. Tsang. 2017. Antimicrobial resistance surveillance in the genomic age. Annals of the New York Academy of Sciences 1388: 78–91.

    Article  Google Scholar 

  • McGonigle, I. 2021. National Biobanking in Qatar and Israel: Tracing how global scientific institutions mediate local ethnic identities. Science, Technology & Society 26 (1): 146–165.

    Article  Google Scholar 

  • McInerney, J.D. 2002. Education in a genomic world. Journal of Medicine and Philosophy 27 (3): 369–390.

    Article  Google Scholar 

  • Meslin, Eric M., and Ibrahim Garba. 2011. Biobanking and public health: Is a human rights approach the tie that binds? Human Genetics 130: 451–463.

    Article  Google Scholar 

  • Mirnezami, Reza, et al. 2012. Preparing for precision medicine. New England Journal of Medicine 366: 489–491.

    Article  Google Scholar 

  • NIH. 2015. Precision Medicine Initiative (PMI) working group report to the advisory committee to the director, 1–108. National Institute of Health.

    Google Scholar 

  • ———. 2017. What is precision medicine? – Genetics home reference. U.S. National Library of Medicine. Retrieved From: https://ghr.nlm.nih.gov/primer/precisionmedicine/definition.

    Google Scholar 

  • Olson, J.E., et al. 2014. Biobanks and personalized medicine. Clinical Genetics 86: 50–55.

    Article  Google Scholar 

  • Parens, E. 2015. Drifting away from informed consent in the era of personalized medicine. Hastings Center Report 45 (4): 16–20.

    Article  Google Scholar 

  • Parikh, Ravi B., J. Sanford Schwartz, and Amol S. Navathe. 2017. Beyond genes and molecules – A precision delivery initiative for precision medicine. New England Journal of Medicine 376 (17): 1609–1612.

    Article  Google Scholar 

  • “Precision Medicine.” 2017. Congressional digest 96 (2): 3–4. Retrieved from: http://search.ebscohost.com.authenticate.library.duq.edu/login.aspx?direct=true&db=afh&AN=120915756&site=ehost-live.

  • Rayan, R.A. 2020. E-health opportunities for the low and middle-income countries. Global Journal of Public Health Medicine 2 (Special Issue 1): 158–163.

    Google Scholar 

  • Rose, N. 2013. Personalized medicine: Promises, problems and perils of a new paradigm for healthcare. Procedia – Social and Behavioral Sciences 77: 341–352.

    Article  Google Scholar 

  • Scott, R.J., et al. 2014. Emerging issues in public health genomics. Annual Review of Genomics and Human Genetics 15: 461–480.

    Google Scholar 

  • Stevens, Hallam. 2015. The politics of sequence: Data sharing and the open source software movement. Information & Culture 50 (4): 465–503.

    Google Scholar 

  • Sabatello, M., and Paul S. Appelbaum. 2016. Raising genomic citizens: Adolescents and the return of secondary genomic findings. Journal of Law, Medicine and Ethics 2 (292): 292–308.

    Article  Google Scholar 

  • Scheen, André J. 2016. Precision medicine: The future in diabetes care? Diabetes Research and Clinical Practice 117: 12–21.

    Article  Google Scholar 

  • Schwab, Abraham P., Barbara Brenner, Joseph Goldfarb, Rochelle Hirschhorn, and Sean Philpott. 2013. Biobanks and the human microbiome. In The human microbiome: Ethical, legal and social concerns, ed. Rosamond Rhodes, Nada Gligorov, and Abraham Paul Schwab. New York: Oxford University Press.

    Google Scholar 

  • Shah, Svati H., et al. 2016. Opportunities for the cardiovascular community in the precision medicine initiative. Circulation 133: 226–231.

    Article  Google Scholar 

  • Śliwczynski, A., and Ewa Orlewska. 2016. Precision medicine for managing chronic diseases. Polskie Archiwum Medycyny Wewnetrznej 126 (9): 681–687.

    Google Scholar 

  • Stoeklé, H.C., et al. 2017. Molecular tumor boards: Ethical issues in the new era of data medicine. Science and Engineering Ethics 24: 1–16.

    Google Scholar 

  • Tigard, D. 2019. Changing the mindset for precision medicine: From incentivized Biobanking models to genomic data. Genetics Research 101 (e10): 1–4.

    Google Scholar 

  • Tutton, Richard. 2010. Biobanking: Social, political and ethical aspects. In Encyclopedia of life Sciences, 1–7. Wiley.

    Google Scholar 

  • Twilt, M. 2016. Precision medicine: The new era in medicine. Ebiomedicine 4: 24–25.

    Article  Google Scholar 

  • Wang, Zheng-Guo, Liang Zhang, and Wen-Jun Zhao. 2016. Definition and application of precision medicine. Chinese Journal of Traumatology 19 (5): 249–250.

    Article  Google Scholar 

  • Zawati, Ma’n H. 2014. There will be sharing: Population biobanks, the duty to inform and the limitations of the individualistic conception of autonomy. Health Law Journal 21 (2014): 97–141.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. California State University, San Bernardino, CA, USA

    Evangel Sarwar

Authors
  1. Evangel Sarwar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sarwar, E. (2023). The Emerging Field of Precision Medicine – The New Paradigm for Healthcare. In: Global Perspectives on Precision Medicine. Advancing Global Bioethics, vol 19. Springer, Cham. https://doi.org/10.1007/978-3-031-28593-6_2

Download citation

Publish with us

Policies and ethics

Search

Navigation